Accuracy and Performance Evaluation of Low Density Internal and External Flow Predictions using CFD and DSMC. [PDF]
Peravali SK +6 more
europepmc +1 more source
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design. [PDF]
Dymock M +6 more
europepmc +1 more source
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol. [PDF]
Paganotti Vicentine M +25 more
europepmc +1 more source
Understanding the Impact of Evaluation Metrics in Kinetic Models for Consensus-Based Segmentation. [PDF]
Cabini RF, Tettamanti H, Zanella M.
europepmc +1 more source
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience. [PDF]
Baccon D +23 more
europepmc +1 more source
Neurological outcomes with hypothermia versus normothermia in patients with moderate initial illness severity following resuscitation from out-of-hospital cardiac arrest: protocol for a multicentre randomised controlled trial (R-CAST OHCA). [PDF]
Naito H +12 more
europepmc +1 more source
Phase II single vs hypofractionated irradiation for timely access to partial breast radiotherapy (SHIFT-PB). [PDF]
Olson R +9 more
europepmc +1 more source
Dose-effect relationship of intravenous tranexamic acid on perioperative haemoglobin drop in total hip arthroplasty (PRADO study): study protocol for a randomised, double-blind, placebo-controlled, dose-response study. [PDF]
Zufferey PJ +4 more
europepmc +1 more source
POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgery. [PDF]
Zarbock A +12 more
europepmc +1 more source

